Encouraging Idea Generation
Developing a screening protocol for pancreatic cancer that detects the early changes in the cancer is complex and requires an interprofessional approach. We actively encourage idea generation and innovation through funded initiatives which seek to bring together individuals with diverse knowledge, skills and capacity for futuring; to challenge current thought and methods, and to construct new models for breakthrough change.
Our esteemed interprofessional Scientific Advisory Board Members share their diverse knowledge and expertise, challenge new ideas through dynamic conversations, and analyze potential innovative projects.
Following the Early Detection of Sporadic Pancreatic Cancer Summit Conference in November 2014 a summative review was published that provided a robust collection of information articulating the current efforts in the field, the analysis of gaps in specific areas of expertise, and the challenges that exist in early detection. This milestone article was authored in response to the urgent need in many fields to clarify what progress has been made in the past and what is necessary now to develop early detection methods for pancreatic cancer.
The four areas of scientific inquiry originally identified for the global summit conference were analyzed in greater depth and reported upon for this paper. Additionally, a separate section entitled Screening in Familial Pancreatic Cancer was included in the Summative Review. It is acknowledged that additional research in the field is being conducted by other investigators and that this document should not be considered an exhaustive review of all possible approaches.
“This ground-breaking paper has received remarkable international response. For the first time, an interdisciplinary group has presented an overview of the current state of the science, analyzed the gaps in specific areas of research, and identified the pressing challenges for developing an effective protocol. I am certain that this paper will have significant impact on many fields as they pursue answers to the numerous questions regarding early detection of pancreatic cancer.”
- Suresh Chari, MD Dr. Chari is a professor of medicine and a consultant in the Division of Gastroenterology and Hepatology at the Mayo Clinic Rochester. He is currently the President of the International Association of Pancreatology and has served in leadership positions in numerous scientific organizations. Serving as a section lead for the Early Detection of Sporadic Cancer Summit Conference and as a member of the KFRF Scientific Advisory Board, Chari has made important contributions to all KFRF initiatives and publications.
The 2015 Forum entitled Early Detection: Lessons Learned from Other Cancers is an important step in the implementation of the Strategic Map for Innovation. Recognizing progress made in other cancers is critical to overcoming barriers in early detection of pancreatic cancer. The Forum will take place on Wednesday, November 4th from 2:00 – 4:30 PM in conjunction with the American Pancreatic Association annual meeting in San Diego, California. This is an opportunity for attendees to gain information from a historical perspective and to engage in vital discussions with leading authorities in the areas of breast, prostate, colon, and lung cancer. Expert panelists include Seema Khan, M.D, Northwestern University; Daniel Lin, M.D., University of Washington; and Kevin Conroy, Chairman and CEO, Exact Sciences.